TITLE

Aloe-emodin suppresses prostate cancer by targeting the mTOR complex 2

AUTHOR(S)
Liu, Kangdong; Park, Chanmi; Li, Shengqing; Lee, Ki Won; Liu, Haidan; He, Long; Soung, Nak Kyun; Ahn, Jong Seog; Bode, Ann M.; Dong, Ziming; Kim, Bo Yeon; Dong, Zigang
PUB. DATE
July 2012
SOURCE
Carcinogenesis;Jul2012, Vol. 33 Issue 7, p1406
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Phosphatidylinositol 3-kinase (PI3-K) amplification and phosphatase and tensin homolog (PTEN) deletion-caused Akt activation contribute to the development of prostate cancer. Mammalian target of rapamycin complex 2 (mTORC2) is a kinase complex comprised of mTOR, Rictor, mSin1, mLST8/GβL and PRR5 and functions in the phosphorylation of Akt at Ser473. Herein, we report that mTORC2 plays an important role in PC3 androgen refractory prostate cell proliferation and anchorage-independent growth. Aloe-emodin, a natural compound found in aloe, inhibited both proliferation and anchorage-independent growth of PC3 cells. Protein content analysis suggested that activation of the downstream substrates of mTORC2, Akt and PKCα, was inhibited by aloe-emodin treatment. Pull-down assay and in vitro kinase assay results indicated that aloe-emodin could bind with mTORC2 in cells and inhibit its kinase activity. Aloe-emodin also exhibited tumor suppression effects in vivo in an athymic nude mouse model. Collectively, our data suggest that mTORC2 plays an important role in prostate cancer development and aloe-emodin suppresses prostate cancer progression by targeting mTORC2.
ACCESSION #
78220789

 

Related Articles

  • Dual specificity phosphatase 6 suppresses the growth and metastasis of prostate cancer cells. XIAOLEI ZHAI; QIANHE HAN; ZHONGJIE SHAN; XIAOWEI QU; LIANG GUO; YUDONG ZHOU // Molecular Medicine Reports;2014, Vol. 10 Issue 6, p3052 

    Dual specificity phosphatase 6 (DUSP6) is expressed at low levels in numerous types of human cancer. The loss of DUSP6 plays a pivotal role in tumor progression; however, the role of DUSP6 in prostate cancer remains unclear. In this study, in vitro invasion assays and in vivo metastasis...

  • Cardiolipin composition correlates with prostate cancer cell proliferation. Sapandowski, Anja; Stope, Matthias; Evert, Katja; Evert, Matthias; Zimmermann, Uwe; Peter, Daniela; Päge, Ilona; Burchardt, Martin; Schild, Lorenz // Molecular & Cellular Biochemistry;Dec2015, Vol. 410 Issue 1/2, p175 

    Prostate cancer (PC) is the second most diagnosed cancer in men. It has been recognized that diet can play a crucial role in PC genesis and progression. In this context, free fatty acids are considered as modulators of cell proliferation. Recently, a relationship between the composition of the...

  • Prognostic Significance of Neuroendocrine Differentiation in Prostate Adenocarcinoma. Sagnak, Levent; Topaloglu, Hikmet; Ozok, Ugur; Ersoy, Hamit // European Journal of Clinical & Medical Oncology;2012, Vol. 4 Issue 3, p7 

    Much progress has been made towards an understanding of the development and progression of prostate cancer (PC), and the factors which drive the development of androgen independence. Neuroendocrine (NE) cells may provide an intriguing link between NE cell differentiation (NED) and tumor...

  • Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies. Tural, D; Serdengecti, S; Demirelli, F; Öztürk, T; İlvan, S; Turna, H; Özgüroglu, M; Büyükünal, E // British Journal of Cancer;4/15/2014, Vol. 110 Issue 8, p1968 

    Background:Overexpression of p185HER2 is an established poor prognostic factor in breast cancer, portending an aggressive course and potential for early metastasis. On the other hand, monoclonal antibody trastuzumab is widely used in the clinic to target this overexpressed oncogene....

  • Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters. Melling, Nathaniel; Thomsen, Erik; Tsourlakis, Maria Christina; Kluth, Martina; Hube-Magg, Claudia; Minner, Sarah; Koop, Christina; Graefen, Markus; Heinzer, Hans; Wittmer, Corinna; Sauter, Guido; Wilczak, Waldemar; Huland, Hartwig; Simon, Ronald; Schlomm, Thorsten; Steurer, Stefan; Krech, Till // Carcinogenesis;Nov2015, Vol. 36 Issue 11, p1333 

    Enhancer of zeste homolog 2 (EZH2) plays an important role in tumor development and progression by interacting with histone and nonhistone proteins. In the current study, we analyzed prevalence and prognostic impact of EZH2 in prostate cancer. EZH2 expression was analyzed by immunohistochemistry...

  • The expression and functional role of FOX transcription factor FOXJ1 in prostate cancer. Qi An; Dezhong Liu; Lian Zou // International Journal of Clinical & Experimental Medicine;2017, Vol. 10 Issue 1, p285 

    As one common malignant tumor in male reproductive-urinary system, the incidence of prostate cancer is increasing rapidly. Recent study revealed the participation of FOX transcription factor family in tumor occurrence and progression. FOXJ1, one member of FOX family, plays an important role in...

  • Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer. Inoue, Takahiro; Ogawa, Osamu // Prostate Cancer (20903111);2011, p1 

    Almost all patients who succumb to prostate cancer die of metastatic castration-resistant disease. Although docetaxel is the standard treatment for this disease and is associated with modest prolongation of survival, there is an urgent need for novel treatments for castration-resistant prostate...

  • Role of Heparan Sulfate 2-O-Sulfotransferase in Prostate Cancer Cell Proliferation, Invasion, and Growth Factor Signaling. Ferguson, Brent W.; Datta, Sumana // Prostate Cancer (20903111);2011, p1 

    Heparan-sulfate proteoglycans (HSPGs) are required for maximal growth factor signaling in prostate cancer progression. The degree of sulfate modification on the covalently attached heparan sulfate (HS) chains is one of the determining factors of growth factor-HSPG interactions. Sulfate groups...

  • Role of the EpCAM (CD326) in prostate cancer metastasis and progression. Ni, Jie; Cozzi, Paul; Duan, Wei; Shigdar, Sarah; Graham, Peter; John, Kearsley; Li, Yong // Cancer & Metastasis Reviews;Dec2012, Vol. 31 Issue 3/4, p779 

    Despite significant advances in surgery, radiotherapy and chemotherapy to treat prostate cancer (CaP), many patients die of secondary disease (metastases). Current therapeutic approaches are limited, and there is no cure for metastatic castration-resistant prostate cancer (CRPC). Epithelial cell...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics